Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Depressive Symptoms and Amyloid Pathology

JAMA Psychiatry(2025)10.1001/jamapsychiatry.2024.4305Source: DataRank Database

Depressive Symptoms and Amyloid Pathology is a research paper published in JAMA Psychiatry (2025). On theSindex it has a DataRank of 0.464. It has been cited 21 times.

N/A

0.464DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 16.55)OA: greenTopics (88)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.464

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (100)

Julie Elisabeth Oomens ORCID,Sebastiaan Engelborghs ORCID,Chris Baeken ORCID,Christine A. F. Von Arnim ORCID,Mercè Boada ORCID

Live enrichment

PubMed:39841452 PMC:PMC11883504 OpenAlex:https://openalex.org/W4406693206

NIA NIH HHS

Grant: P01 AG036694

NIA NIH HHS

Grant: P30 AG072980

NIA NIH HHS

Grant: R01 AG062268

NIMH NIH HHS

Grant: R01 MH120794

NIA NIH HHS

Grant: U01 AG079850

National Institutes of Health

Grant: 5R01NS104147-02

Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)

Swiss National Science Foundation

Grant: 196354

CLearing Alzheimer’s disease Molecular Pathology without medications (CLAMP)

National Institutes of Health

Grant: 5U19AG032438-03

DIAN Genetics Core

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01AG031581-12

PET, APOE & the Preclinical Course of Alzheimer's Disease

National Institutes of Health

Grant: 1U01AG024904-01

Alzheimers Disease Neuroimaging Initiative

National Institutes of Health

Grant: 5U01AG072177-02

KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology

European Commission

Grant: 115372

European Medical Information Framework

National Institutes of Health

Grant: 3P01AG036694-09S2

Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study

FWCI

16.55

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: other-oa

repositoryhttps://pure.amsterdamumc.nl/ws/files/138571955/Depressive-symptoms-and-amyloid-pathology.pdf

repositoryhttps://cris.maastrichtuniversity.nl/ws/files/242296137/Vos-2025-Depressive-Symptoms-and-Amyloid-Pathology.pdf

publisherhttps://jamanetwork.com/journals/jamapsychiatry/articlepdf/2829333/jamapsychiatry_wiels_2025_oi_240086_1740504089.70803.pdf

repositoryhttps://pure.amsterdamumc.nl/en/publications/79a12f30-6778-461b-ab07-80065cd17330

journalhttps://doi.org/10.1001/jamapsychiatry.2024.4305

Fields of Study

Dementia and Cognitive Impairment ResearchFamily Caregiving in Mental IllnessSchizophrenia research and treatment03 medical and health sciences0302 clinical medicineHumansFemaleMaleAgedAmyloid beta-PeptidesCross-Sectional StudiesCognitive DysfunctionMiddle AgedDepressionAged, 80 and overBiomarkersPositron-Emission TomographyAdultPeptide FragmentsApolipoproteins E

MeSH Terms

AdultAge FactorsAgedAged, 80 and overApolipoproteins ECross-Sectional StudiesDepressionFemaleHumansMaleMiddle AgedPeptide FragmentsBiomarkersAmyloid beta-PeptidesPositron-Emission TomographyApolipoprotein E4Cognitive Dysfunction

Keywords

BiomarkerMedicineDementiaDepression (economics)Geriatric Depression ScaleInternal medicineClinical Dementia RatingPopulationApolipoprotein EAmyloid (mycology)PsychiatryPathologyOncologyCognitionDepressive symptomsDiseaseMaleAdultCognitive Dysfunction: cerebrospinal fluidPeptide Fragments: cerebrospinal fluidApolipoprotein E4150Apolipoproteins EAmyloid beta-Peptides: cerebrospinal fluidCognitive Dysfunction: pathologyHumansCognitive DysfunctionBiologyDepression: cerebrospinal fluidinfo:eu-repo/classification/ddc/610Original InvestigationAgedApolipoprotein E4: geneticsAged, 80 and overAmyloid beta-PeptidesDepressionAlzheimer's disease, depression, CSF, biomarkers, amyloid-betaAge FactorsAmyloid beta-Peptides: metabolismMiddle AgedCognitive Dysfunction: metabolismamyloid beta-protein (1-42)Peptide FragmentsCognitive Dysfunction: psychologyCross-Sectional StudiesApolipoproteins E: geneticsPositron-Emission TomographyBiomarkers: cerebrospinal fluidFemaleHuman medicineBiomarkers

Sustainable Development Goals

SDG 0: Good health and well-being